MIRABEGRON

Mirabegron [Cas No. 223673-61-8] is a β3-adrenergic receptor agonist API widely used in treatment of urology. Mirabegron activates β3-adrenergic receptor in urinary bladder and helps in relaxation of detrusor muscle, resulting in increasing bladder storage capacity and reduces urinary urgency and frequency. Mirabegron treats overactive bladder [OAB] and is widely utilised in metabolic research and is key component that targets obesity, weight management as well as metabolic syndrome.

Chemox Pharma manufacturers high purity Mirabegron API in IP/BP/EP/USP standards. We offer high-quality products with high levels of compliance. Our API products are trusted by pharmaceutical industries, which reflects our global footprints and reputation. Our facilities follow the standard regulations of the world like DCGI, WHO-GMP, FDA.